Ashtead Group (LON:AHT) Earns “Buy” Rating from Jefferies Financial Group
Related Articles
-
Neurocrine Biosciences (NASDAQ:NBIX) Rating Reiterated by Needham & Company LLC
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report)‘s stock had its “hold” rating reissued by equities researchers at Needham & Company LLC in a research note issued to investors on Wednesday, Benzinga reports. NBIX has been the subject of several other reports. Barclays upped their price objective on shares of Neurocrine Biosciences from $145.00 to $150.00 […]
-
Jobless rates rise in April for all racial groups except Black Americans
The unemployment rate for Black Americans slid in April, bucking the trend in other demographic groups.
-
Croda International (LON:CRDA) Earns Buy Rating from Jefferies Financial Group
Jefferies Financial Group reiterated their buy rating on shares of Croda International (LON:CRDA – Free Report) in a research report sent to investors on Wednesday, MarketBeat.com reports. The brokerage currently has a GBX 5,300 ($66.57) price target on the stock. Separately, Berenberg Bank restated a buy rating and issued a GBX 5,200 ($65.32) price target […]